Optos Plc

Optos is a global leader in ultra-widefield (UWF) retinal imaging, built on proprietary scanning laser ophthalmoscopy that captures up to 200 degrees of the retina in a single shot-far beyond conventional fundus cameras. Its core strengths lie in multi‑wavelength confocal imaging offering high‑resolution mapping of both posterior and peripheral pathology. The addition of Optical Coherence Tomography to the UWF imaging platform has extended the multimodal capabilities; up to 10 modalities in a single device. The company’s unique value comes from combining speed, patient comfort, and unparalleled field-of-view with image consistency that supports longitudinal disease tracking and AI-ready datasets. Optos holds deep IP across optical design, scanning mechanisms, image registration, and illumination strategies. Positioned within critical technologies, Optos sits at the intersection of photonics, advanced imaging, precision optics, and emerging AI-driven diagnostics-providing foundational infrastructure for population-scale eye screening, early disease detection, and future multimodal ophthalmic analytics.